CareDx, Inc. (CDNA) vs Sotera Health Company (SHC)

CareDx, Inc. and Sotera Health Company are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $5.2B against $3.5B — 1.5× the size. CareDx, Inc. trades at the lower P/E: 29.7× against 31.4×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 8.15%. CareDx, Inc. has the higher net margin (24.2% vs 13.4%) and the higher return on invested capital (130.1% vs 9.82%). Across the 21 metrics below, CareDx, Inc. leads on 14 and Sotera Health Company on 7.

Valuation

Metric CDNA SHC Diagnostics & Research median
P/E 29.68 31.39 35.56
P/S 7.17 4.20 4.37
P/B 7.72 7.68 3.06
Price to free cash flow 39.51 45.36 35.76
EV/EBITDA 22.40 13.18 24.35
EV/Sales 6.36 5.74 5.51
Earnings yield 3.37% 3.19% (1.89%)
Free cash flow yield 2.53% 2.20% (0.15%)

Profitability

Metric CDNA SHC Diagnostics & Research median
Gross margin 70.58% 54.97% 50.89%
Operating margin 23.61% 32.82% (8.57%)
Net margin 24.23% 13.44% (6.37%)
Free cash flow margin 18.49% 9.27% 0.00%
Return on equity 29.49% 27.78% (2.92%)
Return on assets 22.72% 5.01% (6.71%)
Return on invested capital 130.06% 9.82% 0.00%

Growth

Metric CDNA SHC Diagnostics & Research median
Revenue growth (TTM) 34.41% 8.15% 7.69%
EPS growth (last fiscal year) (143.01%) 68.75% 25.92%
Revenue growth, 5-year CAGR 14.59% 7.30% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDNA SHC Diagnostics & Research median
Debt to equity 0.00 3.35 0.11
Current ratio 4.58 2.80 2.02
Net debt to EBITDA 19.49 3.74 0.70

Dividend

Metric CDNA SHC Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric CDNA SHC Diagnostics & Research median
Market cap 3.45b 5.16b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack